When considering a drug for emergency use authorization (EUA), the Food and Drug Administration (FDA) selects an internal advisory committee to review information and data submitted to the FDA by the pharmaceutical company about its new drug. These influential FDA advisory committees, based on that information and data, make recommendations … Continue reading Report 96: mRNA COVID-19 Shots – ‘Vaccines’ or Gene Therapy Products? – Part 2